HAILEY ENTREMONT: Open Payments
NPI 1104120138 · LUTCHER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 24 payments from 8 companies in 2025. Trend: 2023 $192 · 2024 $168 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $252 |
| Amgen Inc. | 9 | $184 |
| Madrigal Pharmaceuticals | 2 | $170 |
| Globus Medical, Inc. | 1 | $33 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: Wegovy, REZDIFFRA, REPATHA, OTEZLA, Senza, LEQVIO, UBRELVY, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
